In the present study we provide a mechanism by which ligand-activated AR, down-regulates estrogen-dependent MCF-7 human breast cancer cell proliferation by inhibiting the ability of E2/ERα signalling to direct transcription of the cyclin D1 gene promoter. The gene discussed is ESR1; the disease is breast cancer.